LivaNova PLC (LIVN:NASDAQ) closed at $80.90 on October 23, 2026, down 0.46% on the day. The stock trades 5.7% below its 52-week high of $85.76 and 65.7% above its 52-week low of $48.82. Over the past year, it gained 47.4%. LivaNova PLC is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
In 252 trading sessions since October 23, 2025, LIVN closed higher on 128 days (51%). Its best day was May 6, 2026 (+15.05%) and its worst was August 5, 2026 (-8.41%). The stock moved 10% or more in a single session 1 time.
LivaNova PLC, a medical technology company, design, develops, manufactures, and sells therapeutic solutions worldwide. It operates in three segments: Neuromodulation, Cardiac Surgery, and Cardiac Rhythm Management. The Neuromodulation segment designs, develops, and markets vagus nerve stimulation (VNS) therapy system, an implantable device for the treatment of drug-resistant epilepsy and treatment-resistant depression, as well as develops transcutaneous VNS devices. This segment serves neurologists, neurosurgeons, hospitals and healthcare systems, and government health departments. The Cardiac Surgery segment develops, produces, and sells cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories, and systems for autotransfusion and autologous blood washing, as well as surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves primarily for perfusionists and cardiac surgeons. The Cardiac Rhythm Management segment develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failures. This segment offers...
Find more stocks like LIVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.